Bittium and Cerenion announce collaboration

Bittium BioSignals Ltd, a subsidiary of Bittium Corporation, and Cerenion Oy announce a collaboration project on bringing advanced brain monitoring into the array of vital signs monitoring available to intensive care staff. The collaboration aims on providing a comprehensive solution for brain electrical activity monitoring for intensive care patients, by combining Bittium BrainStatus™ a wireless EEG-monitoring device meant for real-time brain electrical activity to Cerenion’s innovative C-Trend™ index that interprets EEG signal to a simple score facilitate and accelerate the work of nursing staff.

Recently European CE medical approved wireless Bittium BrainStatus™ EEG amplifier and electrode headband enables high quality and fast EEG signal measurement. Through the use of Cerenion C-Trend™ technology this signal data is turned into a simple score that reveals the status of the patient’s brain at the bed-side and without requiring any changes to the care of the patient.

‘Based on advanced machine learning algorithms and artificial intelligence, the Cerenion C-Trend index transforms the standard EEG signal set into a practical score that is readily interpretable by intensive care staff,’ reported Dr. Timo Koskela, CEO of Cerenion Oy. ‘The C-Trend index coupled with Bittium’s easy-to-use wireless hardware is a perfect match,’ he continued.

‘The easy to wear, wireless and compact Bittium BrainStatus EEG amplifier and electrode headband enables quick measurement up to 24 hours. The EEG measurement score transformed by the Cerenion C-Trend technology makes the interpretation of the measurement easy. This is a functional and easy-to-use solution for the intensive care unit and speeds up the patient’s treatment process,’ said Hannu Huttunen, CEO of Bittium Corporation.

The first line of C-Trend-enabled Bittium BrainStatus devices is expected to become available in 2019.

Contact person

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 40 344 5466



Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2017 were EUR 51.6 million. Bittium is listed on Nasdaq Helsinki.


Cerenion Oy develops the world’s first practical method for measuring the brain function of intensive care patients. Cerenion C-Trend™ technology (pat. pend.) aims to reveal the status of the brain as one simple score – at the bed-side and without requiring any changes to the care of the patient. The solution works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The technology has the potential of improving both the quality and the cost of intensive care.

Source: Cerenion

← Back to news & blogs